IP Library Granted Patent US 7,429,618
Granted Patent B2
US 7,429,618 · App. 11/714,860 · Granted Sep 30, 2008

Potassium channel modulators

Assignee: Neurosearch A/S
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,429,618
App. No.
11/714,860
Granted
Sep 30, 2008
Kind
B2
Abstract

This invention relates to novel compounds useful as potassium channel modulators. More specifically the invention provides chemical compounds useful as modulators of SK Ca and/or IK Ca channels.

Claims (15)

1. A compound represented by the following Formula

any of its enantiomers or any mixture of its enantiomers, or a pharmaceutically acceptable salt therof, or an N-oxide thereof, wherein

m is 1;

n is 0;

X represents fluoro or chloro;

Ar 1 represents a phenyl group substituted with fluoro;

R represents phenyl substituted with fluoro; and

R 1 and R 2 both represent alkyl.

2. The compound of claim 1 , which is

[Tris-(4-fluoro-phenyl)-methyl]-phosphonic acid dimethyl ester;

[(2-Fluoro-phenyl)-bis-(4-fluoro-phenyl)-methyl]-phosphonic acid dimethyl ester;

[(2-Chloro-phenyl)-(2-fluoro-phenyl)-(4-fluoro-phenyl)-methyl]-phosphonic acid dimethyl ester; or

[(4-Chloro-phenyl)-bis-(4-fluoro-phenyl)-methyl]-phosphonic acid dimethyl ester;

any of its enantiomers or any mixture of enantiomers, or a pharmaceutically acceptable salt thereof, or an N-oxide thereof.

3. A pharmaceutical composition comprising a therapeutically effective amount of a compound of claim 1 or claim 2 , or a pharmaceutically-acceptable addition salt thereof, together with at least one pharmaceutically-acceptable carrier or diluent.

Assignments (2)
CONFIRMATORY ASSIGNMENT Recorded Jun 19, 2018
From: NEUROSEARCH A/S
To: SANIONA A/S
Reel/Frame 046381/0799 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 9, 2008
From: POSEIDON PHARMACEUTICALS A/S
To: NEUROSEARCH A/S
Reel/Frame 021050/0961 →
Priority Claims (1)
DK 2002 00013 · Jan 4, 2002 · national
Continuity (2)
Division 1049685900
Related Publication 20070161607A1 · Jul 12, 2007